HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Cost Estimates For Proposed Antibacterials Rule Dwarf FDA’s

This article was originally published in The Rose Sheet

Executive Summary

In comments to FDA, the Personal Care Products Council and American Cleaning Institute challenge agency cost projections and question the need for clinical study data to back the efficacy of antibacterial hand-wash products, as called for in a proposed rule issued by the agency in December 2013. Groups say manufacturers require guidance and request an extension of the deadline for data submissions, current set for December 2014.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel